Background Post-Sepsis Syndrome and Post-ICU Syndrome are terms recently adopted to characterise the health-related quality of life (QoL) issues affecting patients after sepsis or after treatment in an ICU. [1, 2] Whether these syndromes are different is not known. Objectives To determine QoL, late mortality, costs and healthcare resource use of ICU patients with sepsis compared to those without sepsis. Methods After obtaining ethical committee consent we analysed data of ICU patients with sepsis recruited to a randomised controlled trial in New South Wales, Australia. We conducted a cohort and propensity score matched (PSM) analysis using baseline variables including indices of severity of illness compared to ICU patients without sepsis. We assessed QoL using the EQ-5D-3 L at 6 months and mortality, costs (in $AU) and healthcare resource use at 2 years. Results QoL was assessed in 4975 patients: 1320 with sepsis and 3655 without. There were no significant differences in QoL. For the analysis of mortality, costs and healthcare resource use, 3442 patients were included: 905 patients with sepsis and 2537 without. At 2 years, patients with sepsis had higher mortality: 371/905 (41%) vs 860/2537 (34%) HR1.34, 95%CI 1.18 to1.52, p < 0.01; increased costs: ICU: 47,206 ± 55,121 vs 34,142 ± 43,175; p < 0.0001; Hospital: 73,516 ± 61,100 vs 64,676 ± 56,293; p < 0.0001; extended length of stay: ICU: 10.0 ± 11.9 vs 7.1 ± 9.1 days; p < 0.0001; Hospital: 22.7 ± 21.6 vs 20.4 ± 19.7 days; p = 0.003. Patients with sepsis had fewer hospital readmissions: 506/904 (56%) vs 1597/2563 (63%); p = 0.0002. 1612 patients were included in the PSM analysis: 806 with sepsis and 806 without. 90/905 (10%) patients with sepsis could not be matched due to high illness severity. There were no differences in QoL, late mortality or hospital readmissions. Costs were higher for patients with sepsis: ICU 47,298 ± 53,730 vs 38,952 ± 46,778; p = 0.009; Hospital 74,120 ± 60,750 vs 65,806 ± 56,856; p = 0.005, and length of stay: ICU: 10.0 ± 11.9 vs 8.0 ± 9.8 days; p < 0.0001; Hospital: 22.8 ± 21.2 vs 19.1 ± 19.0 days; p = 0.0003. Conclusions Compared to patients without sepsis, patients with sepsis report similar QoL but have increased hospital costs, length of stay and fewer hospital readmissions. Aside from cost, these differences are not significant when patients are matched for severity of illness and other baseline variables, notwithstanding the limitation of our inability to match 10% of patients in the sepsis cohort. Background Sepsis is a life-threatening systemic inflammatory response to infection or trauma associated with, and mediated by, the activation of a number of host defence mechanisms. Neutrophils play an essential role in sepsis by releasing neutrophil extracellular traps (NETs) which exhibit very effective anti-microbial activity. Uncontrolled formation of NETs can, however, become pathogenic particularly via their associated histones that can be cytotoxic in the vasculature causing endothelial cell death, systemic vascular obstruction and multiple organ failure. They can also initiate coagulation by both activating platelets and damaging erythrocytes such that they become pro-thrombotic. Recently we discovered an additional effect of histones on erythrocyte, which is to enhance their fragility when they are subjected to sheer stress associated with blood flow through the vascular system and spleen in particular. In parallel studies our laboratory has synthesised a family of small polyanions (SPAs) which have been screened for their ability to neutralise the pathogenic effects of histones and NETs. Methods We have used a novel mechanically-induced sheer stress method as well as an in vitro spleen filtration model to investigate the effects of mammalian histones ± SPAs, over a wide concentration range, on RBC fragility under both isotonic and hypotonic conditions. The in vitro findings were mirrored in vivo with the injection of histones and SPAs in mice.
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Sepsis is a life-threatening systemic inflammatory response to infection or trauma associated with, and mediated by, the activation of a number of host defence mechanisms. Neutrophils play an essential role in sepsis by releasing neutrophil extracellular traps (NETs) which exhibit very effective anti-microbial activity. Uncontrolled formation of NETs can, however, become pathogenic particularly via their associated histones that can be cytotoxic in the vasculature causing endothelial cell death, systemic vascular obstruction and multiple organ failure. They can also initiate coagulation by both activating platelets and damaging erythrocytes such that they become pro-thrombotic. Recently we discovered an additional effect of histones on erythrocyte, which is to enhance their fragility when they are subjected to sheer stress associated with blood flow through the vascular system and spleen in particular. In parallel studies our laboratory has synthesised a family of small polyanions (SPAs) which have been screened for their ability to neutralise the pathogenic effects of histones and NETs. Methods We have used a novel mechanically-induced sheer stress method as well as an in vitro spleen filtration model to investigate the effects of mammalian histones ± SPAs, over a wide concentration range, on RBC fragility under both isotonic and hypotonic conditions. The in vitro findings were mirrored in vivo with the injection of histones and SPAs in mice.
Results
Our results revealed that free histones bind to RBCs and render RBCs susceptible to lysis by shear stress in a dose-dependent manner both in vitro and in vivo models as well as being retained by the spleen. Some SPAs have been identified that can totally prevent the ability of histones to induce RBC fragility in vitro and anaemia in vivo, with the compounds also preventing the rapid and acute histone-induced thrombocytopenia. Remarkably we have also discovered that the active SPAs can rapidly rescue histone damaged erythrocytes, the fragility of the restored RBCs returning to normal levels within minutes, even following prolonged exposure to histones. Conclusion Based on our in vitro and in vivo data we propose that erythrocytes can capture histones in the circulation and transport them to the spleen for disposal where overload of this disposal system could cause the unexplained anaemia associated with sepsis, cancer and other pathological conditions and our SPAs can both prevent and reverse these effects. Background Neonatal sepsis is one of the major causes of neonatal death in developing countries. Identifying single nucleotide polymorphisms (SNPs) in the genes involved in sepsis may help to understand the pathophysiology of neonatal sepsis. The aim of the present study to look for association between the sepsis in neonates and SNPs in different immune receptor genes involved in host responses to bacterial infection.
P3

Methods
The study involved 151 preterm neonates with signs and symptoms of clinical sepsis and had a blood culture that was positive for a bacterial or fungal pathogen, 136 preterm neonates with signs and symptoms of sepsis along with a positive septic screen but negative blood culture and 146 healthy neonates born between June 2013 to June 2016. A total of 9 SNPs in 6 innate immune related genes were genotyped using PCR-RFLP and Real time SNP genotyping technique. Results Birth weight, gestational age, duration of rupture of membranes, respiratory distress, apnea, abdominal distension, sclerema and anemia were observed in sepsis cases. Incidence of early onset sepsis (EOS) in the blood culture positive neonates was significantly higher as compared to late onset sepsis (p = 0.01). Infections caused due to Gram negative organisms (67.92%) were more common than Gram positive (18.86%) and fungal infections (13.20%). An overall mortality rate among the sepsis cases was found to be 26.82%, however, a higher prevalence of mortality (27.94%) was observed in clinical sepsis as compared to in the proven sepsis (23.17%). Although polymorphisms in innate immune related genes did not show significant association with overall risk of developing sepsis, nevertheless, genotype CT of rs5744168 (TLR5 gene) was associated with a significantly reduced risk of developing sepsis (p =0.02). Genotypes TT of rs2569190 (CD14 gene) and CT of rs5744168 (TLR5 gene) were significantly associated with a reduced risk of developing sepsis in the neonates with bacteriologically confirmed sepsis (p = 0.02) and clinical sepsis (p = 0.03) respectively. Among the patients with bacteriologically confirmed sepsis, genotype CC of rs3804100 (TLR2 gene) was associated with a significantly increased risk of developing severe sepsis (p = 0.02) while same genotype was found to be reduced the risk of developing sepsis (p = 0.04) in the neonates with clinical sepsis. Conclusions This study demonstrates that polymorphisms in the innate immune related genes seems to play a role in sepsis in preterm neonates by influencing susceptibility and the severity of the disease.
Background
Red Cell Distribution Width (RDW) is derived from the routine Complete
Blood Count and provides a simple means to stratify patients by severity of illness to facilitate focused interventions without any additional costs. The rise in RDW among neonatal sepsis cases may therefore reflect the degree of the underlying inflammatory state and provide useful prognostic information about the risk of mortality. The present study was undertaken to look for association of Red cell distribution width (RDW) with neonatal sepsis and sepsis related mortality.
Methods
We performed a prospective observational study on 251 sepsis neonates along with 284 controls. RDW along with other RBC (Red blood cell) indices was performed on an automated cell counter (Sysmex, Japan). We categorized RDW at admission into tertiles of ≤16.9%, 17-20% and ≥20.1%. The cumulative survival rate across the RDW levels during the neonatal period (≤30 days) was assessed using the Kaplan-Meier curve and the log rank test.
Results
Of the RBC indices studied, the median (IQR) RDW levels were significantly higher among the neonatal sepsis cases (19.90%) as compared to the controls (18.90%) (p = 0.001). The rate of mortality due to sepsis was 28.28% and RDW was significantly higher amongst the non-survivors (median: 20.30, IQR: 18.3-23.5) than the survivors (median: 19.80, IQR: 17.5-22) (p = 0.003). Kaplan-Meier curve with log rank test showed that increased RDW tertiles are significantly associated with an increased mortality (p = 0.03) during the 28-day neonatal period.
Conclusions
The present study suggests that increased RDW is associated with neonatal sepsis and could be an independent outcome predictor for mortality associated with neonatal sepsis. The results of this study might help in the effective management of sepsis in neonates.
Background
Sepsis is a very common clinical syndrome, also affecting pediatric population. The main characteristic of this condition is the imbalance of inflammatory response. A relation between immune system and microbiome has been proposed. This study aimed to investigate the effects of symbiotics on systemic inflammation induced in animal models of pediatric sepsis. Methods Animals were supplemented for 15 consecutive days with prebiotic fructo-oligosaccharides (FOS), probiotics (bifidobacterium bifidum, lactobacillus rhamnosus, lactobacillus casei, lactobacillus acidophilus) or symbiotics. On the 15th day, when the animals were 22 days old, endotoxemia was induced by the administration of lipopolysaccharide from Escherichia coli (LPS). Afterwards, oxidative damage was evaluated by measuring TBARS, carbonyl, and systemic inflammation by myeloperoxidase activity (MPO) and cytokines (IL-1, IL-6 and TNF-α) on the brain, kidney, lung ( Fig. 1) , and gut (Fig. 2) . Next, the role of intestinal microbiota through fecal microbiota transplant (FMT) was evaluated. The fecal donor animals received previous supplementation of two probiotic strains (lactobacillus rhamnosus and lactobacillus casei) for 15 consecutive days. The same parameters of oxidative damages and systemic inflammation already mentioned were evaluated on the brain, kidney, lung (Fig. 3) , and gut (Fig. 4) .
Results
In general, results showed that FOS and probiotics treatment was protective against LPS. In addition, strains had different behaviors on each tissue and in each marker, but their protective effect was more pronounced in the gut tissue. When it was evaluated the role of the intestinal microbiota through FMT, it was observed that FMT was protective, independently of previous administration of probiotics to fecal donor groups. Conclusion In conclusion, symbiotics had protective effect upon endotoxemia that was independent of change in intestinal microbiota. However, FMT may offer an additional immunomodulatory benefit that was independent on symbiotic modulation. Keywords: Pediatric sepsis. Probiotics. Symbiotic. Fecal microbiota transplant. Background CD14, Toll-like receptor 4 (TLR4) and TLR4-associated adaptor protein MD-2 are essential receptors involved in lipopolysaccharide (LPS) recognition leading to the synthesis and releasing of pro-inflammatory cytokines among them TNF-α playing a fundamental role [1] . It is well known that p38 MAP kinase pathway is involved in TLR4-dependent TNF-α production triggered by LPS•MD-2 complexes [2] . Recently, it has been shown that the main component from house dust mite Dermatophagoides pteronissinus extract (DpE) -Der p 2 mimics to MD-2 and acts as LPS•MD-2 complex inducing synthesis of pro-inflammatory cytokines [3, 4] . However, LPS•Der p 2 induced Fig. 1 (abstract P5). Effect of cronic administration of symbiotics treatment on damage oxidative and proinflammatory cytokines in the lung of rats submitted to endotoxemia. twelve hours after submitted to endotoxemia, TBARS (A), Carbonyl (B), MPO(C), IL-1b (D), IL-6 (E) and TNFa (E), were measured in the brain. Data are expressed as the mean ± standard deviation for five to seven animals per group (mean ± SD). *Different from Sham + water; #Different from LPS+ water; % Different from LPS + FOS; & Different from LPS + bifidus; $ Different from LPS + rhamnosus; β Different from LPS + casei; @ Different from LPS + acidophilus; p <0.0001, ANOVA on one, followed the Tukey's multiple comparisons test Fig. 2 (abstract P5). Effect of cronic administration of symbiotics treatment on damage oxidative and proinflammatory cytokines in the gut of rats submitted to endotoxemia. twelve hours after submitted to endotoxemia, TBARS (A), Carbonyl (B), MPO(C), IL-1b (D), IL-6 (E) and TNFa (E), were measured in the brain. Data are expressed as the mean ± standard deviation for five to seven animals per group (mean ± SD). *Different from Sham + water; #Different from LPS+ water; % Different from LPS + FOS; & Different from LPS + bifidus; $ Different from LPS + rhamnosus; β Different from LPS + casei; @ Different from LPS + acidophilus; p <0.0001, ANOVA on one, followed the Tukey's multiple comparisons test Intensive Care Medicine Experimental 2017, 5(Suppl 1):37intracellular signaling mechanism is not yet known. In this connection the effect of p38 MAP kinase inhibition on TNF-α production induced by LPS or DpE as well as by their combined action has been elucidated in whole blood model ex vivo. It is necessary to note that an inflammatory mechanism in allergic patients with suspected sepsis has not also fully explained. Methods Whole blood from healthy volunteers was collected into heparinized tubes (5%), diluted with RPMI-1640 medium (1:5 v/v), and transferred into CellStar 24-well tissue culture plates. Blood samples were pre-incubated with 10 μM of p38 MAP kinase inhibitor SB203580 for 15 min at 37°C in a highly humidified atmosphere containing 5% CO2. Then whole blood was stimulated by LPS Escherichia coli O55:B5 (40 ng/ml), DpE (5 000 PNU/ml) or in their combination during 6 h. When incubation period had been finished, the cell culture plates were centrifuged for 10 min at 15°C and 1000 rpm. The supernatants were stored at -20 C until pending analysis. Concentrations of TNF-α in the supernatants were measured by ELISA Kit according to the manufacturer's instructions. Statistical significance was determined by Mann-Whitney U-test.
The incubation of whole blood with LPS E. coli caused cell activation as determined by TNF-α production, whereas combined applying of LPS E. coli and DpE further increased synthesis of TNF-α (Fig. 5) . Very low amounts of TNF-α were detected in the response to DpE alone. Without LPS E. coli or DpE the TNF-α production was almost undetectable. Pre-incubation of whole blood with SB203580 followed by LPS and DpE, either alone or together, resulted in 43% and 48% inhibition of LPS-induced TNF-α production as compared to LPS E. coli or LPS plus DpE, respectively. DpE triggered TNF-α production was inhibited by SB203580 completely (Fig. 5) . These results indicated that the effect of LPS E. coli or DpE on the induction of TNF-α synthesis at least in part depends on p38 MAPK activation. It is necessary to note that there were some variations in TNF-α production triggered by DpE or DpE and LPS E. coli together. These variations may be related to the use of primary whole blood cells rather than cell lines, with different donors having different sensitivities to the applying drugs.
Conclusions
In this study we have found that the synthesis of TNF-α was amplified during combined action of LPS E. coli and DpE. The similar suppressive effect of p38 MAP kinase inhibition on LPS-as well as on LPS and DpE-induced synthesis of TNF-α has been revealed. We have supposed that at least two signaling pathways (NF-kB and AP-1) may be involved in the observed TNF-α production [5, 6] . It seems likely that the DpE leading to TNF-α production does not involve any additional intracellular signaling pathways but probably its effect is realized on the cell surface receptor level [3, 4] . Our study may result in a better understanding of intracellular signaling mechanisms triggered by combined action of LPS E. coli and Der p 2 from Dermatophagoides pteronissinus extract. Background Neutrophils play a crucial role in antimicrobial resistance; evaluation of reactive oxygen species (ROS) production by the neutrophils could provide valuable clinical data on neutrophils' microbicidal capacity. Our aim was to develop a standardized methodology for the neutrophil's oxidative output assessment and to implement it in a clinical practice for management of surgical patients. Methods Oxidative metabolism was evaluated in the whole blood by means of luminol-enhaced chemiluminescence (CL) induced by priming with 50 ng/ml 4-phorbol-12-myristate-13-acetate (PMA) prior to 10 μM N-formyl-methionyl-leucyl-phenylalanine (fMLP) stimulation. We defined an experiment design in order to obtain a signal of high intensity and reproducible pattern. We assessed the time-dependent neutrophils' phenotypic shift by means of CD64, CD16, CD62L, CD11b, CD15 and CD33 expression evaluation after PMA stimulation.
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Results
We revealed changes of CD62L (p < 0,05), CD11b (p < 0,01) and CD15 (p < 0,05) expression as well as CD11b/CD15(high) and CD11b/ CD15(bright) subsets formation (p = 0,001) under PMA priming of the neutrophils. Surface markers expression under PMA stimulation has various impacts on oxidative output kinetics. PMA priming of the neutrophils also leads to a dramatic increase of fMLP-induced ROS production (p < 0,001) that is accompanied by reduction of relative intracellular ROS production (p < 0,001). We built reference CL parameters in a control group of 95 healthy individuals. Investigation of 17 patients with severe burns in dynamics revealed association between intracellular CL insufficiency and development of severe septic complications. We built a fitting linear-logarithmic function to create an unbiased approach to intracellular CL quantification and substantiated clinically relevant kinetic parameters (Fig. 6 ). We used prognostic coefficient C = I2/I3 to perform a precise quantification of intracellular oxidative output in 21 colorectal cancer patients after surgery in dynamics. CD16, CD64 as well as CD11b expression by the CD11b/ CD15(bright) subset drive C to the higher levels (p < 0,05), while CD62L and CD11b expression by the CD11b/CD15(high) subset tend to low C (p < 0,05). Assessment of colorectal cancer patients on the first four days after surgery has shown an increase of C (p < 0,05) as well as CD64+ neutrophils (p < 0,01) and procalcitonin (p < 0,01) levels in patients with longer hospitalization duration due to subsequent inflammatory complications. Conclusion Thus kinetic CL assay being high-sensitive, cost-effective, easy-tostandardize and easy-to-perform, is promising for use in a clinical routine of a surgical hospital.
Background
The decision on the confirmation of the diagnosis of sepsis remains a challenge of neonatology [1, 2] . The purpose of this study was to improve the efficiency of preventive diagnosis of sepsis in newborns with respiratory diseases on mechanical ventilation. 
Chronic comorbid conditions are present in the majority of sepsis patients and these patients have a significantly worse outcome than patients without comorbidities [1, 2] . It is thought that sepsis occurs as a terminal event in a proportion of sepsis patients dying from a disease process other than sepsis [1, 3] .
Methods
We conducted an inception cohort study including all patients admitted to the ICU at a tertiary hospital in Sydney, Australia between October 1st 2016 and December 31st 2016. In all patients diagnosed with sepsis using clinical criteria [4] we used an adjudication system where clinicians estimated the pre-sepsis life expectancy of patients who died in-hospital within 60 days.
Patients who had an estimated life expectancy of less than 90 days were adjudicated to have died with sepsis rather than from sepsis. Results From 864 patients admitted, 146 (16.9%) patients were prospectively diagnosed with sepsis and included (Fig. 7) . Comorbidities were present in 117/146 (80.1%) of patients ( 
Results
In February 2017 we implemented the workflow changes. We will implement our updated algorithm and expect improved specificity. Ten weeks after implementation, rates of compliance with our order set reached 54%, markedly higher than previously implemented order sets at our institution. Nurses now complete screening tasks within two hours in 90% of alerts. We believe that systematic changes to our EHR-based sepsis screening will improve time to delivery and reduce mortality. Conclusions Automated screening for sepsis in acute care hospital wards may be helpful in the early identification and treatment of sepsis. 
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Background
The timing of lactate level measurement and the timing of intravenous antibiotics administration are associated with survival of septic shock patients. Septic shock patients were admitted to medical intensive care unit (MICU) from 2 major sources, hospital ward and emergency department. The differences in management on each sources will affect the lactate and intravenous antibiotics timing. Methods The medical data of adult patients with septic shock from hospital wards and emergency department, admitted to the MICU, Songklanagarind hospital, during January 2015 to December 2016, were collected. Timing of antibiotic administration and lactate level measurement from "time zero" (time diagnosis sepsis) were recorded. The association between timing and risk-adjusted 28-day mortality are assessed. Results Among 150 septic shock patients admitted to medical ICU, 58.7% were from hospital ward. The median time (min) from time zero to antibiotic administration time was higher in hospital ward compared with the emergency department (290.5, interquartile range (IQR), 210 to 486 versus 122, IQR 82 to 212; P < 0.10). With the same trend of lactate level measurement timing (min) (97, IQR, 42 to 164 versus 95, IQR, 57 to 183; P = 0.37). A longer timing of antibiotic administration was associated with higher risk-adjusted 28-day mortality (odds ratio 0.99; 95% confidence interval, 0.99-0.99; P < 0.05). Conclusions Septic shock patients from hospital wards had longer timing of antibiotic administration and lactate level measurement.
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Antibacterial and antibiofilm activity of silver nanoparticles with reducing agent extracted from Eucalyptus coating on endotracheal tube surface: phase I study in the 'PSU endotracheal tube' innovation project
Background Ventilator associated pneumonia (VAP) is a serious complication of mechanical ventilation that has been shown to be associated with increased medical costs and mortality. Bacterial biofilms contribute significantly to the recalcitrant nature of VAP. Commercial silvercoated endotracheal tube (Commercial ETT) had been developed but limit using due to highly cost and using metallic nanoparticles. To create and investigate antibacterial and antibiofilm efficacy of silvercoated green synthesis endotracheal tube with reducing agent extracted from Eucalyptus (AgNPs ETT). Methods Silver nanoparticles and Eucalyptus reducing agents were prepared and coated on endotracheal tubes by electrostatic selfassembly technique. Three types of ETT were compared antibacterial and antibiofilm activity; AgNPs ETT, commercial ETTs and uncoated ETTs. Staphylococcus aureus, Pseudomonas aeruginosa and Actinobacter baumanni were inoculated to form biofilm. We used modified Kirby-Bauer method to identify the diameter of growth inhibition zone (mm), optical density and biofilm formation method to detect antibacterial activity and bacterial adherence respectively. 
Results
AgNPs ETT was found to be most effective in inhibition of P.aeruginosa, followed by commercial ETT and uncoated ETT (4.0 (interquartile range (IQR) 2.2 to 5.0 versus 3.5, IQR 2.6 to 4.4, P = 0.02). This effect also found on S.aureus (3.5, IQR 3.0 to 4.6 versus 3.5, IQR 2.3 to 4.0, P = 0.02) and A.baumanii (4.0, IQR 4.0 to 4.4 versus 3.0, IQR 2.6 to 3.0, P < 0.01). In biofilm formation testing, AgNPs ETT had insignificant bacterial logarithm colony forming unit (log CFU/ ml) when compared with commercial ETT but better than uncoated ETT. Conclusions Silver-coated green synthesis ETT could inhibit bacterial growth and biofilm formation of P. aeruginosa, S.aureus and A.baumanii in vitro. Keywords: Antibiofilm, silver nanoparticle, endotracheal tube, Eucalyptus [1, 2] . Infected organisms use 2 distinct defense mechanisms against infections, i.e. resistance and disease tolerance [3] . Resistance mechanisms aim at reducing the number of pathogens. Disease tolerance is a preserves host homeostasis, without exerting a direct negative impact on pathogens [3] . Instead, it relies on tissue damage control that provide metabolic adaptation and preserves the functional output of parenchymal tissues, maintaining homeostatic parameters within a dynamic range compatible with host survival [4] . Previously, it was shown that expression of the gene encoding the heavy/heart subunit of the iron sequestering molecule ferritin (Fth) is essential for the establishment of disease tolerance in malaria [5] as well as to viral and fungal infections in plants [6] . We hypothesized that expression of Fth protects against the deleterious outcome of bacterial sepsis via affording disease tolerance to infection. Methods We applied genetic loss-of function studies in different knock-out vs. control mice (Mx1CreFthΔ/Δ, AlbCreFthΔ/Δ,LyzMCreFthΔ/Δ, AlbCreERT2G6Pc1Δ/Δ, Tlr4-/-and Ifng-/-) as well as adenovirus-mediated gene overexpresion in C57B6 mice. Mice underwent low-and high grade cecal ligation and puncture (CLP) or peritoneal contamination and infection (PCI) or were administered heme. Survival, disease severity, gene expression, cytokine content, cardio-vascular function, organ damage/dysfunction were assessed. Transcriptomics and hepatic metabolomics performed and integrated in a fluxvariance analysis. Results Here, we provide experimental evidence that deletion of Fth in sepsis is deleterious and that expression of Fth in the liver is critical to control glucose metabolism and establish disease tolerance to sepsis. Deletion of Fth in sepsis does not cause overt organ damage but instead results in failed metabolic adaptation and increased glycolysis, i.e. a parenchymal Warburg effect. The protective effect acts via a mechanism that counters iron-driven oxidative inhibition of the liver Glucose-6-Phosphatase (G6Pase). This is required to prevent the development of septic hypoglycemia that would compromise disease tolerance to sepsis, hence overcoming its lethal outcome. In addition, application of apoferritin reduces sepsis mortality via enhancing disease tolerance infection even when given 6 hours after infection.
Conclusions
Disease tolerance to sepsis relies on a cross talk between host iron and glucose adaptive metabolic responses. Ferritin sustains endogenous hepatic gluconeogenesis. This maintains blood glucose levels in response to infection. The described pathways can be targeted pharmacologically providing a novel therapeutic approach against sepsis that acts independently of pathogens. [1] and the body weight were monitored daily. On the 2nd postoperative day, the abdomen was reopened, 100 μl of 4 kDa FITC-Dextran was injected directly in the distally ligated ileum and quantified one hour later by fluorescencespectrophotometry to measure intestinal permeability. Total RNA was extracted from an ileal bowel specimen and the expression of cytokine and tight junction genes was determined by RT-PCR. Results Septic mice had significantly worse clinical disease scores, lost more weight and had increased intestinal permeability compared to their sham-operated counterparts. After the CLPprocedure, gene expression of IL1β, IL6, Tnfα and Cldn14 were significantly elevated in both vehicle-and IAP-treated mice (Table 3) . Similarly, Occludin and Cldn2 gene expression decreased significantly. IAP-treatment did not result in better clinical outcomes. Nevertheless, IAP did significantly reduce the observed disturbances in intestinal permeability in septic animals ( Fig. 10) . Additionally, IAPtherapy significantly elevated the expression levels of Cldn1 and Cldn14. Conclusion In mice, CLP-induced sepsis is associated with enhanced intestinal permeability, modified expression of intestinal tight junctions and increased expression of ileal inflammatory markers. Treatment of septic mice with IAP significantly lowered the permeability of the intestinal barrier at the small bowel and elevated expression levels of Cldn1 and Cldn14. We expect this increase to be linked to the observed improvements of the intestinal barrier function after IAP-treatment. 
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Background
The main causes of death in ICU are multiple organ failure (MOF) associated with sepsis and refractory septic shock [1] . Concept of mitochondrial dysfunction during sepsis is not new [2] , but it remains unclear what role bacteria play. Our experimental approaches have revealed the influence of aromatic microbial metabolites (AMM) on some mitochondrial function [3] . We want to show how AMM is associated with mortality rates through the development of MOF and septic shock. Methods The study included adult non-survivors patients (N = 91), from which serum samples were taken and frozen for one or two days before the death. Serum samples from 20 donors and 24 survivors of sepsis were as comparison groups. The main equipment: GH-MS (Thermo Scientific) and GH-FID. All chemicals were from Sigma-Aldrich (US). Results One day before death in 100% of cases only three AMM were increased, while other biochemical parameters of organs dysfunction in 9-40% of cases did not exceed normal values (Table 4 ). In the dynamics the closer the moment of death the increase of PhLA, p-HPhAA, pHPhLA were more significant than the growth of other routine parameters and severity scales ( Table 5 ). The serum levels of the mitochondrial metabolites -tricarboxylic acid cycle (TCA) were measured simultaneously with AMM. More than half of septic patients showed a multiple increase in succinic and fumaric acids, also the appearance in the blood of the alpha-ketoglutarate. This can be interpreted as a inhibition of the TCA. Correlations of mitochondrial metabolites (fumaric acid) with AMM (r = 0.68, p <0.01) and among themselves (fumaric with succinic) (r = 0.74, p <0.01) Claudin-2 (Cldn2) 1.14 ± 0.14 1.17 ± 0.12 0.79 ± 0.08* 0.84 ± 0.12* Claudin-14 (Cldn14) 1.13 ± 0.24 2.37 ± 0. were noted. Direct correlation (r = 0.59, p < 0.01) between ∑3AMM and presence of arterial hypotension was found. Only in septic shock patients but never in comparison groups the intermediate (DOPAC) and final (HVA) product of a minor pathway of tyrosine were detected in serum (Fig. 11) . The microbial origin of these metabolites [4, 5] and their ability to inhibit the tyrosine hydroxylase are known [6, 7] . The correlation between ∑3AMM and HVA reached a high rate, r = 0.76. Conclusions AMM can be involved in dying of sepsis: 1) due the development of the MOF via the inhibition of TCA metabolism in the mitochondria and 2) through the mechanism of septic shock by inhibiting of the metabolic pathway of catecholamine synthesis, particularly tyrosine hydroxylase. The search in this direction will help to identify new therapeutic targets to improve the survival in sepsis.
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Can base excess and anion gap predict lactate level in diagnosis of septic shock? Werapon Pongmanee 1 , Veerapong Vattanavanit Background Lactate measurement is the key component in septic shock identification and resuscitation [1] . However, point-of-care lactate testing is not widely used due to lack of access. Biomarkers such as serum lactate, anion gap (AG), and base excess (BE) have been shown to be of use in determining shock in patients with seemingly normal vital signs. Objective To determine if these biomarkers can be used interchangeably in patients with septic shock in the emergency setting based on their test characteristics and correlation to each other. Methods A prospective observational cohort study was undertaken at a tertiary hospital in southern Thailand. Baseline point-of-care BE, AG, and serum lactate were recorded in all patients who presented with septic shock at the emergency department. Overall correlations including area under the receiver operating characteristic curve (AUROC) for both BE and AG to predict serum lactate level were calculated. 
Results
One hundred fifteen patients were enrolled. The median age was 66 years (interquartile range, 52-80 years), and 61% were male. About thirty-five percent of septic shock were pneumonia. Pearson correlation of serum lactate to BE was -0.59 (r2 = 0.35; 95% confidence interval [CI], -0.69 to -0.44; P < .001), that of BE to AG was -0.67 (r2 = 0.49; 95% CI, -0.76 to -0.55; P < .001), and that for serum lactate to AG was 0.64 (r2 = 0.41; 95% CI, 0.52-0.74; P < .001) (Fig. 12) 
Background
The acute phase of sepsis is characterized by the exacerbated production of inflammatory mediators (chemokines, cytokines and nitric oxide). Especially the cytokines may contribute to the intestinal permeability, bacterial translocation and tight junction rearrangement. Cholecystokinin (CCK) was firstly described as a gastrointestinal hormone; however our research group has demonstrated an antiinflammatory involvement of this peptide in experimental models of endotoxemia and bacterial infection. Our aim was to determine the possible role of CCK on lipopolysaccharide (LPS)-induced intestinal epithelial barrier dysfunction. Furthermore, we evaluated its ability to modulate the mucosal inflammatory response and also the expression of proteins of the intestinal tight junctions. Methods To conduct these experiments, male rats had their jugular vein cannulated for endotoxin administration, one day before the experiment. Rats were pre-treated with CCK (0.4 or 40 μg/kg, intravenously) before LPS administration (1.5 mg/kg, intravenously). At 4 h after endotoxemia induction, the intestinal permeability was evaluated by injecting FITCdextran 4 kDa in the ileum and colon; mesenteric lymph nodes were collected for microbiological analysis and also; cytokines were quantified in the plasma and intestinal mucosa by ELISA technique. Additionally, the integrity of the tight junctions was determined by the expression of its constituents proteins (occludin, claudin-1, junctional adhesion molecule-A) and the histological damages were evaluated in tissue sections.
Results
Our results demonstrated that CCK administration reduces the permeability only in the colon and prevented the bacterial translocation to the mesenteric lymph nodes. The levels of pro-inflammatory mediators TNF-α, IL-1β, IL-6 and IFN-γ were reduced in CCK-treated rats, being in the colonic mucosa the most significant effect. Furthermore, treatment with
Fig. 12 (abstract P18).
A-E, Correlation of (serum lactate to BE, AG, correct AG) and (BE to AG, correct AG) CCK attenuated the LPS-induced epithelial barrier dysfunction, increasing the expression of occludin, claudin-1 and junctional adhesion molecule-A. Interestingly, the endotoxemia reduced only the expression of CCK-2 receptors in the colonic mucosa. Meanwhile, the CCK-treated rats showed higher expression of CCK-1 receptor in the mucosa, suggesting the possible mechanism of action for this peptide. Sections of the proximal colon did not evidence of histological damages or the presence of inflammatory cells infiltration.
Conclusions
Our present study sheds light on the fact that CCK treatment breaks the vicious cycle of local gut inflammation and barrier dysfunction in endotoxemia, especially preserving the integrity of one structure of this monolayer epithelium, the tight junctions. Background Recently, studies of the potential usefulness of the mid-regional proadrenomedullin (MR-proADM) as mortality predictor in sepsis has provided interesting results [1,2 3,4] . The aim of our study was to evaluate the accuracy of MR-proADM to predict ICU mortality in septic patients compared with other more frequently used biomarkers, procalcitonin (PCT), C reactive protein (CRP) and lactate, and APACHE II and SOFA scores. Methods This was a single-centre, prospective, observational, cohort, blind study, enrolling septic patients admitted to the ICU of a teaching tertiary hospital between November 2016 and April 2017. Blood samples were taken within the first 18 hours of ICU admission. The accuracy of the biomarkers and risk scores for ICU mortality was evaluated by calculating the area under the receiver operating characteristic (AUROC) curve. Survival was assessed by Kaplan Meier and COX regression analysis. Results Thirty-three consecutive patients with sepsis (20.2%) or septic shock (78.8%) were enrolled. The ICU mortality was 27.3%. The mean age was 69.9 years (standard deviation [SD], 11.6) and 66.7% of patients were male. MR-proADM and lactate plasmatic levels were both significantly higher in non-survivors: 16. Although plasmatic levels of CRP and PCT were higher in the patients who died, this effect was not statistically significant (Table 6 ). MR-proADM showed the best AUROC for ICU mortality prediction: 0.99 (0.98-1; 95% CI) (p < 0.001). CRP levels were not associated with ICU mortality (Fig. 14 and Table 7 ). An optimal cut-off point of 8.58 nmol/L for MR-proADM was selected since it provided a sensitivity of 100% and specificity of 95.5%. Kaplan Meier analysis showed that no patients with a MR-proADM value under this cut-off point died during their stay in the ICU (Fig. 15) . Only MR-proADM and APACHE II were associated with ICU mortality in the multivariate analysis with a hazard ratio of 1.72 and 2.95 (both p < 0.05), respectively (Table 8) . Conclusions A unique determination of MR-proADM plasmatic levels in septic patients measured within the first 18 hours of admission in the ICU has better accuracy for ICU mortality prediction than CRP, PCT, lactate or APACHE II and SOFA scores. Fig. 14 (abstract P20). ROC curves for biomarkers and severity scores with respect to ICU mortality . Accordingly, Melusin levels increase during the compensatory hypertrophy response to stress and decrease during later stages of heart failure [6, 7] . However, its role in LTCC dysfunction associated with sepsis is unknown. We hypothesized that Melusin overexpression could exert a protective effect on cardiac function during septic injury through the increased phosphorilation of AKT, a protein involved in the control of LTCC density in heart cells [8] . An experimental model of septic pre-clinical disease by comparing two different strains of mice have been developed, either with Knockout mice (KO) for Melusin gene (SV129 strain) or with cardiac-specific overexpression (OV) of Melusin (FVB strain). Each group was studied together with a control group. Methods Animals were treated with an intraperitoneal injection of lipopolysaccharide (LPS) at 12 mg/kg to induce a septic state at 0 hours. Measurements and Main Results: At 0, 6 and 24 hours were recorded in both groups, cardiac and hemodynamic parameters through echocardiography and non-invasive detection of blood pressure. Another cohort of animals was sacrificed 6 hours after 20 mg/kg LPS treatment and cardiac tissues extracts were harvested for Western Blot analysis to quantify the expression of AKT, P-AKT and CACNA1C.
Results
In both SV129 WT and KO Melusine mice, fractional shortening (FS) was significantly impaired after LPS challenge and was associated with compensatory tachycardia (Fig. 16 ). After 6 and 24 hours from LPS challenge, in Melusine KO mice, systolic, diastolic and mean arterial pressure were significantly lower than baseline. In Melusin WT mice, these differences were significant only at 24 hours (Fig. 17) . FVB WT mice FS was significantly impaired after LPS challenge and was associated with compensatory tachycardia.In OV mice the tachycardia was also present at 6 hours after LPS challenge. Comparing the two groups, OV mice significantly differ for fractional shortening and heart rate at 6 hours after LPS challenge (Fig. 18) . Consistent with the increased AKT phosphorylation observed in OV mice, the expression of CACNA1C was also significantly higher both at basal levels and after LPS treatment in OV mice compared to WT mice (Fig. 20) .
Conclusions
Melusin has protective role in LPS induced cardiomyopathy, likely through Akt phosphorylation controlling the CACNA1C protein density. 
Background
Sepsis is defined as a dysregulated immune response, but no immunomodulatory therapies have been shown to decrease sepsis mortality. Despite its high clinical heterogeneity, sepsis is still treated as a single disease. Defining sepsis subtypes (or 'endotypes') based on the molecular immune response may allow for a precision medicine approach to match novel therapies to those sepsis patients that can benefit.
Methods
We performed a systematic search of GEO and ArrayExpress for gene expression datasets of clinical studies in sepsis, as previously described [1] . We selected studies of bacterial sepsis, sampled within 48 hours of hospital admission, across a broad range of ages, severities, and geographic locations. We used a batch effect correction algorithm [2] to pool data from 14 bacterial sepsis transcriptomic datasets from 8 different countries (N = 700). We then used a meta-clustering algorithm [3] to find conserved sepsis subtypes across the conormalized discovery samples. We derived a classifier for application in external datasets, and then validated our clusters in 9 independent datasets from 5 different countries (N = 600). Clusters were evaluated for both clinical and molecular differences in both discovery and validation datasets. Results Meta-clustering revealed three sepsis subtypes, which, based on gene ontology analysis, we termed Inflammopathic, Adaptive, and Coagulopathic. We derived a 33-gene classifier with an overall 83% accuracy in leave-one-out re-assignment of the discovery data. We then applied this classifier to identify the same 3 subtypes in 9 independent datasets (N = 600). Across both discovery and validation, we showed that the Inflammopathic subtype is associated with younger age, higher clinical severity and higher mortality; the Adaptive subtype is significantly associated with a lower clinical severity and lower mortality; and the Coagulopathic subtype is significantly associated with both older age and clinical coagulopathy. Further, these clusters are significantly associated with clusters derived by others in independent, single-study sepsis cohorts [4] [5] [6] [7] [8] .
Conclusions
We identified three sepsis subtypes (Inflammopathic, Adaptive, and Coagulopathic) associated with significant difference in mortality among sepsis patients. These sepsis subtypes may assist in the development of targeted therapies that would fail if applied to all patients with sepsis [6] . The consistent presence of the sepsis subtypes across a broad range of patients from multiple studies around the world suggests their potential for use as a single framework to better define heterogeneity in patients with bacterial sepsis. Background There are many biomarkers and therapies for sepsis used in clinical practices, but few become the standard. Histidine-rich glycoprotein (HRG) is a plasma glycoprotein produced in the liver, and its plasma concentration is around 80-100 μg/ml. Our group reported that plasma HRG levels decreased in mice with sepsis, and supplemental HRG infusion significantly improved survival rate in mice model of sepsis [1] . We also showed that HRG produced strong inhibition of subsequent immunothrombosis, DIC state, hypercytokinemia, and activation of vascular endothelial cells [1] . Moreover, in our clinical study, we performed a prospective observational study of patients with systemic inflammatory response syndrome (SIRS). We found HRG levels were significantly lower in SIRS patients with infection than in those without infection, and HRG could be a novel diagnostic and prognostic biomarker for SIRS patients. In this study, we focused on the HRG levels in patients with sepsis, and assessed the differences of HRG levels between non-survivors and survivors. Methods This study was multicenter, prospective, observational investigation. We studied ICU patients who were newly diagnosed as sepsis. We collected blood samples within 24 hours of ICU admission, and HRG levels were determined with a quantitative enzyme-linked immunosorbent assay (ELISA). Data were expressed as median and interquartile ranges (IQR, 25th to 75th percentiles). We used Mann-Whitney U test for comparisons between the groups. We also applied Cox proportional hazard model to analyze relationship between HRG levels and mortality. Results Ninety-nine septic patients from 11 institutes in Japan were included. HRG levels were significantly lower in nonsurvivors (n = 16) than in survivors (n = 83) (15.1 [IQR, 12.7 -16.6] vs. 30.6 [IQR, 22.1 -39.6] μg/ml; p < 0.01) (Fig. 21) . Survival analysis revealed that HRG levels were associated with mortality (Hazard ratio 0.78; p < 0.01), and the Harrell C-index (predictive power) for HRG was 0.90. Furthermore, when patients were divided into two groups according to HRG levels using the cutoff value of 19.6 μg/ml, lower HRG group represented significantly higher mortality (p < 0.01) (Fig. 22) . Conclusions We studied 99 septic patients and demonstrated that initial HRG levels were significantly lower in non-survivors than in survivors. We also found that HRG levels at ICU admission were associated with mortality. These results suggested that HRG could be a novel prognostic biomarker for septic patients. Background Improved biomarkers are required for the detection of sepsis at the point of care (POC). Upregulation of surface CD64 expression (the neutrophil CD64 index, nCD64i) has been extensively studied as a sepsis biomarker, but such assays are not amenable to use at POC. We hypothesised that simultaneous measurement of neutrophil CD64 and a neutrophil-specific protein in whole blood could yield a surrogate of the nCD64i that would be feasible for development of a simple immunoassay-based POC test. To test this hypothesis, we evaluated the relative levels of total CD64 and neutrophil elastase in whole blood of healthy controls and patients with clinically diagnosed sepsis. Methods We are recruiting adult ICU patients (n = 50) with clinically suspected sepsis (Alfred Hospital ICU, Melbourne) and healthy individuals (n = 50). Levels of a selected neutrophil specific marker, neutrophil elastase (NE), and neutrophil activation marker (CD64) are measured by commercial sandwich ELISA kits in detergent lysed whole blood. Samples were also tested using the Leuko64™ assay (Trillium Diagnostics) (surface CD64), and total (surface and intracellular) expression of CD64 was confirmed by flow cytometry staining, and microscopy. Results A strong correlation between total (whole blood) CD64 and NE was observed in healthy individuals (n = 30, R 2 = 0.7, p < 0.0001, Fig. 23 ). Surprisingly, the total amount of CD64 reached a threshold at NE levels of only 4 μg/ml (Fig. 23) . We established assay cutoffs (mean + 2SD) for CD64 and NE as well as a "Gating" strategy for healthy levels of CD64/ NE (Fig. 23) . In sepsis patients analysed to date (n = 11), the Leuko64 kit was positive in 8/11 patients. Conversely, total CD64 and/or NE was highly elevated in all except one myelopenic sepsis patient (10/11 positive, CD64 p < 0.0001, NE p = 0.0002 relative to healthy controls), suggesting that the expected upregulation of neutrophil-CD64 during sepsis includes intracellular CD64 that is detected by ELISA, but not by the Leuko64 assay. Flow cytometry also demonstrated high levels of intracellular CD64 in selected samples that were negative by Leuko64.
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Conclusion
We observed saturated levels of CD64 with moderate levels of NE in controls, compared with the presence of large amounts of total CD64 (including intracellular CD64) and/or NE in whole blood of sepsis patients. Our results suggest that measurement of both total CD64 and NE levels in whole blood has promise as an improved candidate biomarker for diagnosis of sepsis compared with the detection of surface CD64 (nCD64i, Leuko64) or plasma NE. Background MOTREM is the clinically formulated synthetic peptide (LR12) that is currently being developed for the treatment of sepsis and for the prevention of sequelae after acute myocardial infarction. Preclinical experiments have demonstrated that LR12 is able to modulate inflammatory responses and prevent their deleterious consequences in various animal models at a pharmacologically active dose of 1 mg/kg/h [1] [2] [3] . Its pharmacological action occurs via the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) signalling pathway. MOTREM was safe and well tolerated in GLP toxicology studies. Methods Twenty-seven healthy male volunteers have been included in this clinical trial. The product was administered by continuous intravenous infusion (CIV). A single ascending dose design with 8 dose levels was used. Cohorts 1 and 2 received a 15-minutes single dose of MOTREM (1 and 10 mg and one and two volunteers respectively). Then, cohorts 3 to 8 received either a 15-minutes loading dose (from 0.5 mg/kg to 5 mg/kg) followed by 7.75-hours maintenance dose (from 0.03 mg/kg/h to 6 mg/kg/h) of MOTREM or a matching placebo (3:1 ratio). All volunteers were carefully monitored. Before escalation to the next dose level, safety and PK data of the previous dose level were reviewed by a safety review committee. Two follow-up visits were done at Day 8 and at Day 28. Since immune system is at rest in normal individuals and thus TREM-1 pathway is not activated, no pharmacodynamics parameters were analyzed. The main objective of this trial was then to study the safety and pharmacokinetic profile of MOTREM.
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Results
No product related changes in vital signs, clinical nor laboratory parameters were observed. No product-related adverse events were reported. The PK of MOTREM was linear; The main clearance was estimated at 463 L/h/70 kg which is higher than the hepatic blood flow in human (i.e., 90 L/h/70 kg) and is therefore indicative of an extensive enzymatic metabolism in blood; effective half-life was calculated to be about 3 minutes Conclusions MOTREM was found to be safe and well tolerated up to the highest dose tested (5 mg/kg for a 15-minutes loading dose and 6 mg/kg/h for a 7.75-hours maintenance dose). Safety and pharmacokinetics of MOTREM is currently being studied in septic shock patients in a phase IIa randomised, double-blind, twostage, placebo controlled, international, multicenter clinical trial (www.clinicaltrials.gov NCT03158948). Background TREM-1 (Triggering Receptor Expressed on Myeloid cells-1) is an immunoreceptor initially known to be expressed on neutrophils and monocytes/macrophages. TREM-1 plays an important role during the pathogenesis of sepsis by amplifying the inflammatory response. Modulation of TREM-1 through the administration of the LR12 peptide was linked to beneficial effects in several preclinical sepsis models [1 -3] . This study aimed to explore the mechanisms by which the clinical stage LR12 peptide prevented sepsis-induced cardiovascular dysfunction.
Methods
Two hours after induction of fecal peritonitis, rats and mice were randomized to receive a unique 3 mg/kg intraperitoneal dose of LR12 or vehicle. Animals with laparotomia but without CLP served as controls (sham). Ex vivo vasoreactivity of mice aortic and mesenteric arteries was measured in response to phenylephrine (Phe) and acetylcholine (Ach). The activation of constitutive (Akt,eNOS) and inducible (iNOS,COX-2) endothelial pathways was assessed by WesternBlot and qRT-PCR. Survival, MAP (Mean Arterial pressure), blood lactate, intrinsic cardiac parameters and pharmacological effect of LR12 were monitored in rats. We evaluated the expression of Trem-1 in murine vessels and murine and human isolated endothelial cells by flow cytometry, qRT-PCR and confocal-microscopy. Results Arteries from septic mice treated with LR12 showed better vasoreactivity as compared to untreated animals. These results were confirmed in aortic and mesenteric arteries from healthy animals after in vitro stimulation with LPS or a TREM-1 agonist. We observed a reduction of the phosphorylated forms of constitutive proteins (Akt,eNOS) and in the expression of the inducible pathways (iNOS,COX-2) along with a decrease in the expression of inflammatory mediators (TNF-a,IL-6,IL-10) in arterial vessels costimulated with LR12. In rats, TREM-1 pharmacological inhibition by LR12 was associated with preservation of MAP, decreased lactate levels and an improved cardiac function as well as survival. We unexpectedly observed by qRT-PCR and confocal microscopy that TREM-1 was expressed in aorta from animals, and inducible in vivo during sepsis. These results were confirmed in isolated mice and human endothelial cells. LR12 was able to decrease the LPS-induced TREM-1, TNF-a and IL-6 expression. Conclusions We report here for the first time that TREM-1 is expressed and inducible in endothelial cells during sepsis. We also showed that it plays a direct role in endothelial dysfunction responsible for alteration of vasoreactivity. These results shed new lights on the mechanism of action through which the TREM-1 inhibitory peptide LR12 displays a strong protective effect on cardiovascular function in experimental sepsis models. We recently demonstrated that TREM-1 is expressed by endothelial cells and that the pharmacological inhibition of TREM-1 by the clinical stage LR12 peptide displayed protective effects on the endothelium in polymicrobial sepsis. This study aims to assess the effect of a constitutive and a targeted deletion of TREM-1 on endothelial cells during experimental sepsis models.
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Methods
We generated constitutive Trem-1 KO (TREM-1-/-) as well as endotheliumconditional TREM-1 KO (EndoTREM-1-/-) mice and submitted them to polymicrobial sepsis through CLP. Organs (Bone marrow (BM), spleen, lungs, aorta and mesenteric artery) and blood were harvested at different time points and analysed for cellular content (Flow cytometry), gene expression (qRT-PCR), cytokine/chemokine concentrations (ELISA), and vasoreactivity (Myograph). Survival was monitored for 1 week. Results During CLP-induced sepsis, TREM-1 constitutive deletion altered inflammatory cells mobilization and recruitment in lungs/spleen and favours the accumulation of reparative cells (Ly6Clow monocytes and M2 macrophages) in the lungs. This effect was even more pronounced in EndoTREM-1-/-. Consequently, the activation of many inflammatory genes was reduced in the lungs as well as the concentrations of various cyto/chemokines (MCP-1, VCAM-1, IL6). Sepsis induced a profound vascular hyporeactivity in WT mice which was prevented in TREM-1-/-mice. Interestingly, in EndoTREM-1-/-, while vasoconstriction was still slightly impaired, endothelium-dependent vasodilation remained intact. Finally, survival was improved in the Trem-1-/-group and even more in the EndoTREM-1-/-group.
Conclusions
The targeted deletion of endothelial TREM-1 confers protection during septic shock in modulating inflammatory cells mobilization and activation and restoring vasoreactivity. The mechanism by which cellular recruitment is reduced is probably linked to a reduction of chemokines production by endothelial cells. The effect of abolition of Trem1 on vascular tone, while impressive, deserves further investigations. Background Quick Sequential Organ Failure Assessment (qSOFA) was introduced in the 2016 to identify high-risk patients with sepsis outside the intensive care unit (ICU). However, the value of qSOFA criteria the emergency department (ED) setting is unclear. We performed this prospective study to investigate the value of qSOFA, Systemic Inflammatory Response Syndrome (SIRS) criteria and Modified Early Warning score (MEWS) for predicting mortality and ICU admission within 30 days after presentation at the ED. Methods All patients visiting the ED between November 2016 and May (19th) 2017 with suspected or proven infection were enrolled in this prospective study. All components of SIRS, qSOFA and MEWS were collected at presentation at the ED. Sensitivity, specificity and the area under the receiver operating curve (AUROC) were calculated for predicting mortality and ICU admission. Results Of the 267 included patients, 12 (4.5%) died within 30 days after presentation at the ED. Presence of two or more SIRS criteria predicted mortality with 66.7% sensitivity and specificity of 50.6%. For qSOFA ≥ 2 a sensitivity of 8.3% and specificity of 94.9% was found. A MEWS ≥ 3 predicted in-hospital mortality with 66.7% sensitivity and specificity of 58.8%. Discrimination for mortality was highest for qSOFA ( [1] . Methods The research was carried out on 27 male mice of the C57Bl/6 line, weighing 18-20 g. The animals were randomized into 5 groups of 6 animals each mice, the fifth, (control) group consisted of 3 animals. 0.5 ml of daily broth culture of Pseudomonas aeruginosa 1840, isolated under burn disease, was injected intraperitoneally way in the dose from 1 × 103 CFU/ml to 1 × 106 CFU/ml. The control group animals were injected with 0.5 ml of sterile isotonic solution of sodium chloride. General condition of the experimental animals was monitored twice a day. At the terminal stage of the experiment the animals were euthanized, and anatomized according to a conventional technique. The extracted hepar and kidneys were fixed with 10% neutral formaline and poured into paraffin blocks. Serial sections 4 μm thick were stained with haematoxylin and eosin and analyzed in a light microscope ("AxioPlus", Carl Zeiss, Germany). Results Hepar histological changes of all experimental animals were almost identical, although they differed in severity. Significant damage of hepatic lobule structure and hepatocyte lamina, as well as replacement of hepar pulp with amorphous eosinophil matter were obtained. The veins and capillaries of the liver showed signs of stasis of blood, veins contained fibrin clots. Other areas of hepar pulp were infiltrated with white cells, many hepatocytes showed signs of destruction. The marked changes were most pronounced in animals that received the maximum infectious dose of P. aeruginosa. Kidneys histological changes among the animals of all experimental groups were similar and characterized by an abrupt drop in blood filling of capillary glomerulus of cortical and juxtamedullary nephrons. Shumlyansky-Bowman capsules of the cortical nephrons were widened, while visceral layer capsule, juxtaglomerular complex and mesangium cells showed nucleus pycnosis signs. The epithelial cells of proximal convoluted tubules of cortical nephrons looked swollen with sharply enlightened cytoplasm and signs of vacuolar dystrophy. The apical parts of the epithelial cells were destroyed and the formed cellular detritus partially or completely blocked the lumens of the tubules. There was practically no destruction of the proximal tubules in the unfiltered juxtamedullary nephrons [2, 3] . Conclusions Hepar and kidneys reactive histological changes in the murine model of experimental sepsis used are characterized by a number of differences based upon the histological structure specifics of their microcirculatory bloodstream. 
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Background
To report the incidence of sepsis according to the 3rd International Consensus definitions (Sepsis-3) [1] within critical care (prevalence at admission to critical care, and incidence over time), and the relative contribution of component organ dysfunction. To gain further insight into antibiotic prescribing in critical illness. Methods A multi-centre cohort study using a prospectively defined and validated, high-quality research database (NIHR Health Informatics Collaborative). Elective surgical admissions and those missing core physiology or mortality data were excluded. Sepsis was defined as an increase (delta) in the Sepsis-related Organ Failure Assessment (SOFA) score of two or more within a calendar day of a new antibiotic prescription (assuming no organ dysfunction prior to critical care). Setting: Ten adult critical care units from five NHS teaching hospitals in the UK between 2014-2016. Results Of 17,829 critical care admissions (15,132 patients), 12,086 admissions (10,196 patients) were available for analysis after excluding 5,743 elective surgical admissions. We identified 14,272 episodes of life-threatening organ dysfunction (median delta-SOFA 4 [IQR 3 to 8]), predominantly around admission (point prevalence 87% [10,447]). The subsequent incidence was 61 per 1,000 patient days. Deteriorations at admission were largely driven by respiratory (30%) and cardiovascular (28%) organ dysfunction. 2,402 of all cases (17%) were compatible with the Sepsis-3 consensus definition for shock [2] . 14,090 courses of antibiotics were prescribed to 8,502 (70%) of admissions, with 53% (7,461) initiated at admission. Antibiotics were escalated during 7,110 (49.8%) lifethreatening organ dysfunction events meeting the operational definition of Sepsis-3. Of these, 1,739 (24.5%) met the additional criteria for septic shock [ Fig. 24 ]. This translated into a point prevalence of sepsis on admission of 56% (6,754 admissions), and a subsequent incidence rate of 5. Background New diagnostic tests in sepsis are generally evaluated and compared in patient cohorts for which there are varying degrees of confidence in the clinical reference diagnosis for each patient. In these cohorts, even small amounts of uncertainty in the clinical reference diagnosis can have large influences on reported sensitivity and specificity that are unrelated to the true diagnostic test performance. This effect influences almost every reported sepsis diagnostic performance to date, but is rarely quantified or reported although it should be for the same reason that confidence intervals are required to contextualize results. There are currently no tools available for non-statistician researchers to address this problem. Methods Using simulations and empirical data from sepsis trials, we show the effect of uncertainty in clinical reference diagnosis on the reported performance for diagnostic tools for sepsis. We present open-source software that automatically corrects for this effect to give more accurate performance metrics for sepsis diagnostics and can be applied retrospectively. This tool is freely available as an easy-to-use web interface that allows non-specialist researchers to upload their data to have these corrections applied. Results We show examples of sepsis datasets for which there is sufficient uncertainty in the clinical reference diagnosis that although sensitivity and specificity are well defined, the values are statistically not meaningful. We also show the results of our software tool in normalizing performance to account for clinical uncertainty, allowing more robust comparison of molecular diagnostics over patient cohorts and between diagnostic tests. Generally, we show the usage of this tool to correct values for AUC, sensitivity, specificity, PPV and NPV in a range of sepsis datasets with varying degrees of uncertainty in the clinical reference diagnosis, for both binary diagnoses (positive/negative) and for diagnostics with a variable scale (i.e. ug/L). Conclusions The use of this tool allows sepsis researchers to quantify to what extent the results of a new diagnostic test are reliable in the context of uncertainty in clinical reference diagnosis. This tool can be used to identify when reference uncertainty is sufficiently high that new diagnostic performance results should be offered with caution, or not reported at all. Conversely, it may be used to qualify high confidence performance results for new tests. This tool converts the problem of uncertainty in reference diagnosis into a solution of bounding diagnostic performance estimates of new tests.
P35
A combination of thalidomide and clarithromycin prevents acute lung inflammation in mice suffering from Klebsiella pneumoniae B5055 induced pneumonia Vijay Kumar 1 , Sanjay Chhibber Background Despite existing antibiotic therapies, acute lung injures due to acute lung infections (i.e. pneumonia) are a major cause of mortality and morbidity in both developing as well as developed countries. Agents with potent antiinflammatory as well as immunomodulatory properties are required to prevent tissue injury. These agents should be able to suppress the deleterious effects of inflammation, while leaving the protective response intact. In the present study a combination of thalidomide (THD) and clarithromycin (CLM) is used to observe their tissue protective effect in mouse model of acute lung infection induced by Klebsiella pneumoniae B5055. The two are used together as clarithromycin has both antibacterial as well as antiinflammatory properties and thalidomide has immunomodulatory property. Methods Pneumonia was induced by intranasal instillation of Klebsiella pneumoniae B5055 (104 cfu/ml) by holding the mice in upright position without any anaesthesia. Experimental animals were divided into four groups (i.e. Group A; control (oral saline), Group B; clarithromycin (CLM) (30 mg/kg/day/os), Group Background Despite significant advances in life support of critically ill patients, sepsis remains a major cause of mortality worldwide [1] . Currently, most sepsis patients survive the initial sepsis episode to enter a prolonged state of immune deactivation, termed sepsis-induced immunosuppression, which accounts for treatment failure and death due to secondary infection(s) [2] . While the clinical impact of sepsis immunosuppression is well recognized, the underlying mechanisms remain unknown. Evermore, the failure of over 100 clinical trials on sepsis immunotherapy has been largely attributed to the lack of reliable biological measures that discriminate patients with immune deactivation [2] . We recently demonstrated the major role of a specialized autophagy pathway termed LC3 associated phagocytosis (LAP) in immunity against the major human fungal pathogen Aspergillus fumigatus [3, 4] . Because A. fumigatus is an emerging pathogen in ICU patients recovering from sepsis, we explored whether defective LAP is implicated in sepsis immunosuppression. Methods In a prospective study we evaluated phagocyte function in adult patients (>18 years old) admitted in the ICU of two University Hospitals with community-acquired septic shock. Monocytes isolated during early (Day1) and late (Day 7) phase of sepsis were stimulated with A. fumigatus bioparticles and phagosome biogenesis was assessed by confocal imaging. Phagosome studies were also performed in a physiologically relevant model of peritonitis in mice with different degree of sepsis severity. Results We identified a distinct group of patients (12/30, 40%) who developed LAP blockade in monocytes upon sepsis recovery (Fig. 25) . LAP blockade was associated with broad phagosome biogenesis defects and impaired phagolysosomal fusion, TLR hypo-responsiveness, increased severity of illness (higher APACHE II score) and significant increase in risk for development of secondary infections (P = 0.04) (Fig. 25) . Experiments in the CLP model of polymicrobial sepsis mirrored the findings of human studies by demonstrating selective inhibition of LAP in macrophages of mice recovering from severe sepsis, without evidence of LAP defect in macrophages obtained from mild sepsis or sham control mice (Fig. 26) . Importantly, studies in macrophages from cytokine KO mice demonstrated a causal relationship between deregulated cytokine signaling pathways and LAP defects (Fig. 27) . Conclusions Our study provides a novel mechanistic link between defects in molecular pathways regulating phagosome biogenesis and development of sepsis immunosuppression. Delineating the molecular mechanism of sepsis-induced LAP blockade will pave the way for personalized medicine and novel immunomodulatory therapies in sepsis. 
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Low endocan levels at ICU admission are predictive of acute respiratory distress syndrome in severe sepsis and septic shock Alexandre Gaudet 
Background
Endocan is a circulating proteoglycan dosed at high blood levels during severe sepsis, with a likely lung anti-inflammatory role [1] [2] [3] . Data from a pilot study suggest that paradoxically low blood levels of endocan at the acute phase of severe sepsis could predict Acute Respiratory Distress Syndrome (ARDS) within 72 h [4] . The main objective of this study was to confirm the prognostic value of low blood levels of endocan at the acute phase of severe sepsis to predict ARDS. Methods We constituted a validation cohort in a prospective single-center observational study including patients admitted for severe sepsis in the Intensive Care Unit (ICU) of a French University Hospital, between October 2014 and March 2016. Blood endocan was measured at inclusion. Criteria for ARDS were evaluated at 12 h, 24 h, 48 h and 72 h following inclusion. The primary outcome was a lower endocan blood level at inclusion in patients with ARDS at 72 h. Results 100 patients admitted in ICU for severe sepsis were included. 31 patients met criteria for ARDS at 72 h. Endocan blood values at inclusion were significantly lower in patients who met the criteria of ARDS at 72 h (p = 0.01). For each elevation of 1 ng/mL of endocan, the adjusted OR for presence of ARDS at 72 h was of 0.93 (95% CI 0.86 -0.998; p = 0.045). In our cohort, an endocan value < 2.54 ng/mL predicted ARDS at 72 h with a positive predictive value of 0.75 (Sp = 0.97 (95% CI 0.9 -1)). Conclusions In a validation cohort of severe septic patients, we confirmed that low blood levels of endocan at ICU admission are predictive of ARDS at 72 h. Background Acute respiratory Distress Syndrome (ARDS) is a severe respiratory failure, occurring in up to 20% of patients admitted in ICU with severe sepsis [1, 2] . Despite years of research, the prognostic of ARDS remains associated with high levels of mortality, reaching up to 50% in most severe forms [3] . Dysregulated leukocyte diapedesis is a major mechanism leading to the constitution of ARDS [4] . Endocan is a 50 kDa circulating proteoglycan, secreted by lung endothelial cells under pro-inflammatory conditions, which might inhibit leukocyte diapedesis by blocking the interaction between the integrin LFA-1 and its endothelial ligand ICAM-1 [5] . On a clinical point of view, paradoxically low blood levels of endocan during acute systemic inflammatory states are associated with the occurence of ARDS [6, 7] . This could be explained by a lack of lung anti-inflammatory activity in patients exhibiting low blood levels of endocan. At the opposite, this association could be explained by a potential pro-inflammatory role of endocan's major catabolite, p14, which has been dosed in the plasma of septic patients [8] . The objective of this study was to evaluate the respective roles of endocan and of its major catabolite p14 in the regulation of leukocyte diapedesis. Methods We explored in vitro the roles of endocan and p14 in the control of human T cell transendothelial migration, as well as in ICAM-1 mediated migration and ICAM-1 dependant adhesion. We also evaluated at the molecular scale the impact of p14's binding to LFA-1 on the endocan/LFA-1 interaction. Finally, we explored the effect of p14 on the ICAM-1/LFA-1 interaction. Results In our in vitro study, endocan inhibited human T cell transendothelial migration, as well as ICAM-1 dependant migration and ICAM-1 mediated adhesion. At the opposite, p14 had the ability to reverse endocan's effects on T cell transendothelial migration, ICAM-1 dependant migration and ICAM-1 mediated adhesion. Our molecular study revealed that p14 could bind to the integrin LFA-1 and inhibit the endocan/LFA-1 interaction. Finally, we could not observe any effect of p14 on the interaction between LFA-1 and ICAM-1.
Conclusions
The results of our study highlight the ICAM-1 dependant antimigratory effect of endocan on human leukocytes. Our study also reveals the potential role of p14 as a biological competitor of endocan, consisting in the restoration of leukocyte diapedesis through restoration of the LFA-1/ICAM-1 interaction.
Background During previous investigations, we assessed the diagnostic and prognostic role of several sepsis markers including C-reactive protein (CRP), sCD25, IL-10, procalcitonin (PCT), IL-35 and presepsin [1] [2] [3] . Furthermore, our group mechanistically evaluated PCT in in vitro models of sepsis, thus demonstrating the LPS binding and neutralizing activity of PCT [4] . In this study, we were aiming to estimate which group of microorganisms were causing sepsis, on the basis of PCT serum levels, in order to contribute to a timely and appropriate management of this often fatal syndrome Methods This retrospective observational clinical study was conducted using clinical and routine laboratory data collected from June 2016 to June 2017. Blood cultures (BC) and serum samples were serially collected from each patient with suspected sepsis, defined according to the most recent guidelines [5] . Only the first sample, obtained during the first septic episode, was evaluated for each patient. Samples for blood cultures were obtained under aseptic conditions in all patients, incubated and monitored for seven days by BacT/Alert 3D system (bioMérieux, France). The isolated microorganisms and antibiotic susceptibility were assessed by standard clinical microbiology methods or automated systems. Serum PCT levels were measured by VIDAS B.R.A.H.M.S. PCT (bioMérieux, France), in the samples of enrolled patients, as well as in samples of a group of non-bacteremic controls. Statistics were obtained using ANOVA, as well as PLSD post hoc test. Receiver-operating characteristic (ROC) analysis was also performed. A p < 0.05 was considered statistically significant. Results From our data, we can estimate different levels of PCT in different patients stratified by the microorganism isolated in their blood cultures. More specifically the PCT concentration in patients infected by an Enterobacteria organism was very significantly (p = 0.0001) different from patients associated with Gram-positive sepsis. Also, we found that levels of PCT in Nonfermentative Gram-negatives were significantly lower (p = 0.014) versus Enterobacteria-caused sepsis. Similarly, PCT showed a significantly lower (p = 0.031) concentration in fungal sepsis in comparison to sepsis caused by Enterobacterial organisms (Fig. 28) . Conclusions Previously we demonstrated that presepsin levels are differentially affected by different type of blood culture isolates, whose Enterobacteria were associated with very high presepsin levels. Similarly, in the present study, significantly higher PCT concentrations were found in sepsis cases, where blood culture isolates belonged to Enterobacteria. Background Rapid identification (ID) and antimicrobial susceptibility testing (AST) are crucial to start appropriate antibiotic stewardship particularly in septic patients. The identification of organisms and drug resistance phenotype characterization from positive blood cultures generally takes several days. However, recently developed rapid diagnostic methods offer the potential for organism identification within only a few hours of blood culture positivity. The aim of this study was to evaluate the performance of an automated microscopy-based multiplex FISH assay to rapidly identify organisms directly from positive blood cultures and perform drug resistance phenotype. Methods Sixty two positive blood cultures, obtained from critical patients admitted to Pugliese-Ciaccio Hospital of Catanzaro (Italy), were analyzed by automated Accelerate Pheno™ System (Accelerate Diagnostics Inc.) and in parallel compared to conventional methods by Vitek2 or automated mass spectrometry microbial identification system that uses MALDI-TOF technology (bioMérieux®).The Accelerate Pheno™System identified microbial cells using a broad panel of fluorescence in situ hybridization (FISH) probes in parallel channels. Following a one hour pre-growth and automated dilution step, remaining sample was automatically split and immobilized in separate flowcells for identification phase of the assay (90 min) and AST testing (7 hr). Single concentrations of each appropriate antibiotic in cation-adjusted Muller-Hinton broth with 0.94% agar were introduced into each flowcell. Automated microscopy captured time-lapse images of each flowcell which were used by the computer software to analyse growth rates and other characteristic features of each individual immobilized progenitor bacterial cell during growth. An algorithm converted bacterial growth or inhibition for each tested antibiotic into a minimum inhibitory concentration (MIC) value. No matching data were also evaluated by molecular method (FilmArray, bioMérieux®) .
Results
Of the overall 62 positive blood cultures tested, six specimens were not included in the analysis due to cassette error of the instrument. Data obtained by the Accelerate Pheno™ System was confirmed in 82.1% (46/56 cases) when compared to Vitek2 method or automated mass spectrometry microbial identification system while in 17.9% (10/56 cases) were discordant. The method was not capable of consistently identifying polymicrobial cultures in their entirety recognizing, in one blood culture, Klebsiella pneumoniae but not Candida parapsilosis since not included in the panel, or completely failing. Concerning antibiotic susceptibility testing, the Accelerate Pheno™System showed a concordance of 86.8% when compared to Vitek2 method.
Conclusions
The data of this study demonstrated that the Accelerate Pheno™ System appears a rapid and valid method for identification and antibiotic susceptibility assessment directly from positive blood cultures. Rapid AST results provide information necessary for optimization of antimicrobial stewardship. 
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Background
Sepsis has been classically defined as the exuberant, harmful, proinflammatory response to infection. This concept is changing [1] and the presence of a dysregulated host response to infection causing life-threatening organ dysfunction is now considered a central event in the pathogenesis of the disease [2] . Quantification of the expression of immunological genes participating in the pathogenesis of sepsis could represent a new avenue to improve its diagnosis. The aims of this study are 1) to quantify immunological dysfunction in surgical patients with presence/absence of sepsis using a droplet digital PCR (ddPCR) transcriptomic analysis. 2) To evaluate this approach for improving identification of sepsis in these patients. Methods Expression of the neutrophil protease gene (LCN2/NGAL) and also of a gene involved in the immunological synapse (HLADRA) were quantified in blood from 101 surgical patients with sepsis, 53 uninfected surgical patients and 16 blood donors by using ddPCR. Areas under receiver operating characteristic curves (AUROC) and multivariate regression analysis were employed to test the ability of the LCN2/HLA-DRA ratio to identify sepsis, in comparison with procalcitonin. Results Sepsis induced over-expression of a neutrophil protease gene (LCN2) and depressed expression of an immunological synapse gene (HLA-DRA). LCN2/HLA-DRA outperformed procalcitonin in differentiating between patients with sepsis and surgical controls in the AUROC analysis ( (Table 9 ). Gene expression levels of HLA-DRA were an independent marker of hospital mortality. Conclusions Quantifying the transcriptomic ratio LCN2/HLA-DRA by ddPCR is a promising approach to improve sepsis diagnosis in surgical patients. Background Septic shock is defined as a subset of sepsis in which underlying circulatory, cellular, and metabolic abnormalities are associated with a greater risk of mortality than sepsis alone [1] . Septic syndrome represents the major cause of death among critically ill patients worldwide, constituting an important public health problem [2] . In this sense, leukocytes and its subpopulations are crucial components of the innate immune response and the first line of defense against infection [3] . The role of the different leukocyte subsets in the prognosis of severe infections has been studied in different works but these studies have somehow forgotten the basophil. The aim of this study was to evaluate the ability of basophil count in blood to predict mortality in septic shock. Methods We performed a two-stage multicenter, retrospective study, aimed at evaluating the potential role of leukocyte subpopulations in patients with septic shock and no immunosuppression. The Derivation Cohort accounted with 238 patients and the Validation Cohort with 186 patients. Statistical analyses were performed to evaluate the impact of basophil count on mortality at 28 days. Results When patients of the Derivation cohort were distributed into groups based on deciles for basophils count at 28-days for mortality prediction, 110 basophils was selected as cut-off. Patients with > 110 basophils/mm3 died earlier (Fig. 30) . Multivariate COX regression analysis demonstrated that showing > 110 basophils was an independent predictor of mortality (p = 0.048 and HR = 2.32) ( Table 10 ). The cut-off identified in the Derivation Cohort was tested in the Validation Cohort. Kaplan-Meier survival analysis (Fig. 30) and COX regression multivariate analysis confirmed the results obtained in the Derivation cohort (p = 0.012 and HR = 2.288) (Table 11 ). Conclusions Our study reveals a previously unnoticed association between basophil counts and mortality in septic shock. Background Sepsis can be defined as the life-threatening organ dysfunction due to a dysregulated host response to infection [1, 2] . Acute systemic inflammation can activate the innate immune system, launching a cascade of physiological and behavioral changes ultimately affecting the central nervous system (CNS) [3] . Some of these CNS alterations resemble the pathophysiological mechanisms of neurodegenerative diseases [4, 5] . Animals submitted to sepsis induced by cecal ligation and puncture showed increased amyloid beta (Aβ) peptide deposition in brain structures, and this fact is related to cognitive impairment [4] . In this context, the aim of this study was evaluated the effect of inhibition of the amyloidogenic pathway on the deposition of beta-amyloid peptide in brain structures and on the behavior of animals submitted to sepsis. Methods Male, Wistar, adult rats were used to perform the experiment. Initially, the activity of secretases in brain structures of septic and non-septic animals was determined. Sepsis was induced using the technique of cecal ligation and perforation (CLP). Next, the animals were divided into three groups: Sham, Sepsis and Sepsis + Inhibitor. The sepsis + inhibitor group received treatment with a beta or gamma secretase, or Aβ inhibitor on the 7th, 8th and 9th day after induction of sepsis. The animals were submitted to behavioral test to evaluate memory retention on the 15th day after induction and later sacrificed to remove structures, prefrontal cortex and hippocampus, for Aβ determination by Western Blot. Data were analyzed using SPSS with 95% confidence interval. Results The activity of beta and gamma secretase were significantly increased in prefrontal cortex and hippocampus 10 and 30 days after sepsis induction, supporting the hypothesis that neuroinflammation promoted by sepsis stimulates Amyloid Precursor Proteins cleavage for amyloidogenic pathway (Fig. 31) . Animals treated with all inhibitors when submitted to the inhibitory avoidance test, showed significantly longer latency time than the control group, demonstrating that inhibitors treatments prevents cognitive damage (Fig. 32) . In animals treated by betasecretase inhibitor, Aβ peptide was significantly lower in hippocampus in 15 days and in 30 days was observed reduction in prefrontal cortex deposition, when compared to control (Fig. 33) , suggesting that the inhibition of enzymes participating in the amyloidogenic pathway can reduce Aβ peptide deposition in brain structures.
Conclusions
We conclude that inhibition of the amyloidogenic pathway decreases Aβ peptide expression in brain structures reducing long-term cognitive damage due to sepsis. Background Life-Space Assessment Score (LSA) [1] is an established metrics of mobility by asking about movement in areas ranging from one' s bedroom (LSA = 0) to beyond one' s town (LSA = 5). Among elderly patients with sepsis, physiological age such as mobility function is often different from their chronological age. We hypothesized that LSA is a risk factor for 28-day mortality in elderly patients with sepsis, independent of their chronological age. Methods Design: A single-center retrospective cohort study Objective: To determine whether baseline restricted life-space is associated with 28-day mortality in the elderly patients with sepsis Setting: Mixed-ICU with closed system, tertiary and teaching hospital in Kamogawa City in Japan, where population aging rate (age > = 65 years old) is higher than 30% [2] . Population: All elderly (age > = 65 years old) patients with sepsis admitted to the ICU between September 2014 and January 2017 were included. Sepsis was diagnosed with Sepsis-3 criteria [3] . Background Within Emergency Department (ED) sepsis patients, delayed deterioration resulting in shock is associated with an increased risk of death. Heparin-binding protein (HBP), a neutrophil-released serum biomarker, has been shown to be elevated in patients developing delayed shock. The objective of this study was to assess the performance of HBP to predict delayed shock among sepsis sub-populations. Methods This was a secondary analysis of a pooled database of patients enrolled into one of two prospective, multi-center observational studies of adult patients from five Swedish and two United States EDs admitted with suspected or confirmed infection. HBP levels were drawn upon ED arrival. Patients were excluded if they were hypotensive [systolic blood pressure (sBP) < 90 mmHg] upon ED arrival. The primary outcomes were: 1) early shock (eShock) = any sBP < 90 within 12 hours and 2) delayed shock (dShock) = any sBP < 90 that occurred between 12 and 72 hours after arrival. Controls were defined as patients without shock within 72 hours from arrival. Sepsis subpopulations were defined a priori by age and source of infection. Univariate logistic regression models were utilized to identify independent predictors associated with each outcome. Results Over 34 months, 1055 patients were enrolled, with 962 for this analysis after exclusion criteria applied. HBP levels were significantly higher in eShock (p30 ng/mL) was associated with progression to Developing a systematic framework to process EHR data will provide insight into disease progression and enable the operationalization of EHR data in clinical practice.
Background
In the context of sepsis, challenges to detection and diagnosis are exacerbated by extremely complex cascade of events. Little is known about how evidence-based knowledge is integrated into clinician mental models that often underlie human decision-making. Fuzzylogic cognitive mapping has potential to measure and assess perceptions of sepsis diagnosis both individually and collectively. Taking a human systems engineering approach, the objective of this research is to present differences in mental models among clinicians' diagnosis of sepsis. Methods This qualitative study used purposive sampling, a semistructured interview process for data collection, and fuzzy-logic cognitive mapping techniques for analysis. Semi-quantitative models were developed to evaluate the differences between clinician type (e.g. physician, nurse), practice setting (e.g. emergency department, intensive care), and sepsis expertise. Results defined important components in the sepsis diagnosis process, the relationships between these components, and the degree of influence that one component can have on another, defined using qualitative weightings. Results Qualitative static models were translated into semi-quantitative dynamic models. Analysis of clinician responses indicated that there was wide variability in clinicians' mental models for sepsis diagnosis but revealed similar themes once responses were organized in a structured terminology platform. Findings also indicated that clinicians identified as "experts" exhibited a clear, focused shared mental model. Conclusions Mental models influence how clinicians' behave due to their ability to affect perceptions of reality and can be used to connect values and beliefs that drive organization culture to a commitment to clinical care goals. Addressing variability in terminology and preconceived ideas about sepsis diagnosis will lead to important advances for early diagnoses and appropriate management to improve patient care. Background Pentraxin 3 (PTX3) is a fluid phase pattern recognition molecule, which has served as a paradigm for linking the cellular and humoral arms of innate immunity. PTX3 is an important component of host resistance to pulmonary infections with selected microorganisms, including Aspergillus fumigatus and Pseudomonas aeruginosa. Our aim was to investigate the role of PTX3 in the control of pneumococcal infections caused by Streptococcus pneumoniae, the most common causative bacteria in community-acquired pneumonia and an important cause of mortality world-wide. Methods By using a model of invasive pneumococcal infection in mice, we analyzed the local colonization and the bacterial translocation (pneumococcal count in the lung and spleen respectively). PTX3 expression was characterized during the different stages of the infection using different techniques (mRNA analysis, ELISA and immunohistochemistry). Neutrophil recruitment were evaluated by measuring the myeloperoxidase (MPO) levels by ELISA. Binding of PTX3 on S. pneumoniae was realized with a specific assay revealed by Western Blot. Results A strong expression of PTX3 is observed at the local site of the infection but also in the systemic compartment following the invasive kinetic of the infection, in correlation with an important upregulation of PTX3-inducing cytokines (e.g TNF-α and IL-1β). With immunohistochemistry analysis we find a specific expression of PTX3 localized at the bacterial site of infection at earlier time points. We also found that human and mouse PTX3 specifically bind on S. pneumoniae, independently of the polysaccharide capsular composition and expression. Comparing the pneumococcal load in PTX3 deficient and competent mice, we observed a higher sensitivity of Ptx3 -/-animals during the invasive phase of the infection. Interestingly, the intranasal administration of recombinant PTX3 to Ptx3 -/-restored the sensitivity to the pneumococcal infection at the level of PTX3 competent mice. We also showed that an exogenous local instillation of PTX3 during the ongoing infection is able to reduce the pulmonary pneumococcal load. Our first results finally indicate that S. pneumoniae opsonized with PTX3 prior the infection are controlled more efficiently in the lung (compared to unopsonized bacteria) but only after the neutrophils recruitment in the respiratory tract. Conclusions Our results suggest a non-redundant role of PTX3 in the control of S. pneumoniae infections. Given that neutrophils are important for the control of pulmonary pneumococcal infection we are currently characterizing the effect of PTX3 on opsonophagocytosis of S. pneumoniae. This will allow to characterize a possible mechanism involved in PTX3 control of pneumococcal pneumonia.
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Coding and long non-coding RNA networks of specific peripheral blood mononuclear cell subsets in sepsis Brendon P. Publicly available data of Illumina microarrays were retrieved for 1 ng/kg and 4 ng/kg LPS doses. We recruited an additional 8 healthy volunteers who received 2 ng/kg LPS intravenously with blood for microarrays (Affymetrix human genome U219 chips) collected at 4 hours post-LPS. After background correction, the different microarray studies were combined for meta-analysis by firstly re-mapping probes to the current Genome Reference Consortium Human genome build 38 (GRCh38) available via GenCode. Gene expression data were subsequently normalized and adjusted for non-experimental chip effects. Data were analyzed by moderated t statistics and enrichment of canonical signaling pathways performed by Ingenuity Pathway Analysis. Results Differential gene expression analysis of 1 ng/kg, 2 ng/kg and 4 ng/kg LPS doses relative to pre-LPS (baseline) uncovered 6044, 4796 and 5893 significantly altered genes, respectively. Both unique and common transcriptional signatures were identified, with 638 commonly altered and 2267 uniquely altered genes dependent on LPS dose. Pathway analysis of elevated genes as a function of LPS dose revealed 27 canonical signaling pathways that included death receptor signaling, protein ubiquitination, PI3K/AKT and IL-6 signaling. Genes with decreased expression as a function of LPS dose significantly over-represented 12 pathways including EIF2 signaling, oxidative phosphorylation and mitochondrial dysfunction. Conclusion Shared and distinct cellular biological pathways were identified that responded quantitatively to different LPS doses. Genes involved in translation (EIF2 signaling), metabolism (oxidative phosphorylation, mitochondrial dysfunction) and cell death (death receptor signaling) represented major cellular biological pathways influenced by LPS dose.
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The circulatory small non-coding RNA landscape in health and community-acquired pneumonia Hina Naz-Khan We here sought to firstly identify differentially abundant circulatory small non-coding RNA in CAP patients as compared to healthy subjects, and secondly delineate those putatively targeted cellular pathways. Methods The study comprised 10 intensive care CAP patients with culture proven infection and 5 healthy subjects. Blood plasma (EDTA) was collected for small RNA isolation and processed for small RNA next generation sequencing (Solexa). Sequence alignments were done against the current Genome Reference Consortium Human genome build 38 (GRCh38) available via GenCode. Results In health we found 127170 small non-coding RNA sequences, with a preponderance of microRNA (93.5% of total). Other small RNA species were also detected that included small nucleolar (sno)RNA and small cajal-body (sca)RNA, accounting for 6.5% of circulatory small RNA species. In CAP patients we found 120943 sequences, with microRNA as the most abundant species (85.2%). We uncovered 24 differentially abundant circulatory microRNA (13 high, 11 low; adjusted p < 0.05) in CAP relative to health. Pathway analysis of the high abundance microRNA revealed an over-representation for PI3K-AKT, mTOR, TNF and AMPK signaling pathways, including hsa-miR-100, hsa-miR-483 and hsa-miR-501. Low abundance circulatory micro-RNA were associated to TGF-beta signaling and cell cycle pathways that included hsa-miR-146b, hsa-miR-744 and hsa-miR-191.
Conclusion
In both health and CAP small RNA molecules were detected in the circulation with microRNA the dominant species. Pathway analysis of the differentially abundant microRNA in CAP relative to health suggests metabolic, cytokine and cell cycle pathways may be in the cross-hairs of those circulatory microRNA. 
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Background
The purulonecrotic lesions of lower limbs is one of the most frequent surgical implications of diabetes mellitus (DM), the results of the treatment of which, unfortunately, have not been satisfactory [1, 2] . The diabetes mellitus prevalence in different countries is from 1 to 6% [3] . Methods The serial industrial samples of Decasan medicinal products of YURiA FARM production and Octinesept Schulke production were used in the researches. The conclusion of antisepsis efficiency was drawn based on whether there was microbial growth in medium after 48 hours of incubation at the temperature of 37°C. Each indicator was identified according to the results of the test conducted three times. The clinical effectiveness of Decasan was studied in the course of the treatment of 275 inpatients with purulonecrotic lesions. Results The index of the minimal bactericidal concentrations fully reflects the sensitivity of a certain strain of microorganisms to the main active ingredient of the antimicrobial remedy when growing in artificial conditions and is taken into account when selecting concentration of antimicrobial compound being part of finished dosage form. The results of the study of sensitivity of clinical strains of microorganisms to Decasan and Octenisept are given in the Table 15 . Analyzing the obtained results, high sensitivity of a wide range of opportunistic microorganisms to the antiseptic medications under study should be pointed out. The sensitivity of individual types to each of the medications, however, significantly differed. Decasan has found wide application in the practice of purulent surgery, where it is used for local treatment of patients with purulent lesions of soft tissues of different localization. Decasan was heated before use to 37-38°C and was used to rinse wounds after opening of abscess, phlegmon, carbuncle, boil, whitlow and paraproctitis. The period of complete wound healing was reduced to 2.5 days. The duration of inpatient stay of patients with phlegmons and abscesses reduced from 14.97 and 15.18 days to 12.33 and 10.8 days respectively. Conclusions Decasan antiseptic medication has high antimicrobial activity with respect to a wide range of pathogenic and opportunistic microorganisms and potent antiseptic properties, and, therefore, should be used for prevention and treatment of microbial diseases. The experience of the clinical use of Decasan shows its high medical effectiveness in purulonecrotic lesions of different localization, lack of undesired side effects and economic efficiency of a wide medical use.
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Expediency of the different biomarkers use for diagnosis and monitoring of perinatal sepsis treatment of the newborns with surgical pathology Gennadiy Khanes (androshchuk@hotmail.com) Neonatal Surgery Department, Ukrainian National Pediatric Hospital OkhMatDyt, Kyiv, Ukraine Intensive Care Medicine Experimental 2017, 5(Suppl 1):P61
Background
The main role in perinatal sepsis appearance is played by intranatal and contamination infections, both bacterial and fungal, and immature immune biologic activity of an organism. The redundant secretion of cytokines (interleukins) happens under the influence of bacterial, viral and fungal toxins, also the humoral and cell immunity is disordered as discharge of bacterial antigens and of complement system and coagulatory hemostasis disorder. Methods The experience of treatment of newborns with postoperative and bone and joint sepsis showed that during 3 days of the decease we noted critical values of coagulatory tests such as APTT -more than 50 sec, TT -clot absence, PDF -8.0 and more, Fn 10 ng/l was observed during intestinal perforation, peritonitis, aspiration pneumonia; it exceeded 2 ng/l during pyelonephritis development against the background of different kidney malformations or tumors. The high level of C-reactive protein (CRP > 24 mm/l) was observed in early stage of the decease in cases of severe sepsis and only in 2 weeks after the beginning of the decease in case of SIRS. Results The undertaken monitoring shows that normalization of coagulatory tests is connected with effective surgical treatment, adequate antibacterial therapy, introduction of specific immunoglobulin and to a lesser extent with using protease inhibitors. The main point in diagnostics and treatment of perinatal sepsis is the determination of etiologic factor of bacterial, viral or fungal origin by serologic and PCR methods. The determination was made during the treatment of all patients and allowed to choose the adequate therapy. This investigation showed that bacterial infections caused sepsis in 90% cases, viral -in 10%. The 30% of clinical observations showed the joining of fungal infections as well. Background The aim of the study was to study the clinical efficacy of polymyxin adsorption in gram-negative sepsis in cancer patients.
Methods
The study included 86 patients aged from 47 to 84, who were operated for oncological diseases of the abdominal cavity, postoperative period was complicated by Gram-negative sepsis (qSOFA > 2, PCT > 2 ng/ml, EAA 0.45-0.9. Microbiological confirmation of sepsis was obtained in 76% of cases, of which 45% of the isolated microorganisms were multiresistant. At the time of the diagnosis of sepsis, the severity of the condition by APACHE-II scale was 28.6 + 3.1, by SOFA scale: 18.2 + 4.7. In 64 of 86 patients (74.5%), the development of MNT required organ replacement therapy. All patients received standard sepsis therapy (Surviving Sepsis Campaign: International Guidelines, 2015). Adsorption was performed by immobilized Polymyxin cartridge B "TORAYMYXIN PMX-20R" (Japan). Adsorption was performed with a cartridge with immobilized polymyxin B "TORAYMYXIN PMX-20R" (Japan). The beginning of the procedure is 2-6 hours after the diagnosis of sepsis. Blood flow velocity is 120-150 ml/min, duration is 240 minutes. All patients underwent two sessions of LPS-adsorption at intervals of 24 hours. PCT and EAA were determined before LPS adsorption and 24 hours after each procedure. Results After the completion of the selective lipopolysaccharide-adsorption program, optimization of the clinical course of generalized inflammation was observed in 87% of cases: regression of hyperthermia, a statistically significant decrease in the level of leukocytes and neutrophils in peripheral blood, improvement of biochemical parameters of blood. In 89% of patients, EAA declined and values were below 0.4. PCT blood levels decreased significantly in 92% of observations. Against the backdrop of inclusion in the complex intensive treatment of lipopolysaccharide adsorption in 62% of cases, there was a decrease in the need for vasopressor support in connection with the optimization of the hemodynamic profile. After the final procedure of sorption therapy, 42 of 64 patients had no need for further organ-replacement therapy. LPSadsorption did not cause adverse events. Lethality was 21.9%. Conclusions Inclusion of lipopolysaccharide adsorption into intensive therapy of Gram-negative sepsis can effectively stop the manifestation of bacterial endotoxin systemic effects and improve the results of cancer patient hospital treatment period.
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One year follow-up of patients with purulent-necrotic complications of lower limb and sepsis -importance of compliance on postoperative prognosis Aleksandra V. Shalaeva, Bakhtiyor B. Janabaev, Azam R. Bobabekov, Nailya A. Dadabaeva, Evgeniya V. Shalaeva Tashkent Medical Academy, Tashkent, Uzbekistan Correspondence: Aleksandra V. Shalaeva (aleksandrashalaeva@gmail.com) Intensive Care Medicine Experimental 2017, 5(Suppl 1):P63 Background Sepsis is a common cause of mortality and morbidity worldwide. Early and appropriate empiric antimicrobial therapy and surgical intervention are critical in decreasing mortality and morbidity. A systematic review by Winters et al suggested that beyond the standard 28-day in-hospital mortality endpoint, ongoing mortality in patients with sepsis remains elevated up to 2 years and beyond [1] . In addition, survivors consistently demonstrate impaired quality of life [2] . The purpose of the study was to evaluate the impact of compliance in 1-year prevention of major adverse events (MAE) in patients with sepsis. Methods This is a prospective single center interventional cohort study. We included 82 symptomatic patients (49 male and 33 female) of 57 ± 9.2 years old with sepsis undergoing surgical treatment for purulentnecrotic complications of lower limb from January to December 2013 in Tashkent Medical Academy. Patients were examined every day at the hospital, and every month after discharge during 1-year follow-up. Patients' consent was received at day of admission to the Academy for diagnosis, in-patient treatment and 1-year follow-up examination. Results Baseline patients' characteristics are shown in Table 17 . During the examination period 28(34.1%) patients strictly comply with the prescribed antibacterial, antifungal treatment, life style changes (stop smoking, alcohol intake), treatment of comorbidities (arterial hypertension, coronary heart disease, diabetes and al.). 54/82 patients (65.8%) were non-compliant. In 46 patients (56%), blood culture was positive. Staphylococcus species were detected in 18 (39.1%), Streptococcus species 9(19.5%), Enterococcus species in 3(6.5%), Klebsiella species in 12 (21.4%), E. coli in 8 (14.2%), Pseudomonas aeruginosa in 11 (23.9%) patients. Candida species were the most frequent fungi that cause sepsis in 27 patients (58.6%). During 1 year examination, we detected significant decrease of new admissions for inpatient treatment for purulent surgical complications, MAE, such as cardiac death and myocardial infarction, pulmonary embolism, p < 0.05 (Table 18) . Kaplan-Meier curve of survival after death is shown in Fig. 38 . Conclusions Patients with good compliance showed twofold decrease risk for MAE. Compliance initiatives are vitally significant in septic patients to decrease the risk of reactivation of infection, purulent-necrotic complications, cardiac death, and pulmonary embolism. Background Type 2 diabetic (T2D) patients with the lower extremity artery disease are at the highest risk of lower limbs purulent-necrotic complications and sepsis. The aim of the study was to evaluate the prediction of the synovial tendon complex injury (STCI) on the incidence of septic complications in T2D patients. Material and methods In this prospective single center interventional cohort study, we evaluated 179/331 consecutive symptomatic T2D patients (mean age 60.4 ± 8.8 years) without a history of cardiac events undergoing trans-femoral amputation (TFA) during the year 2013, who had no contraindications for computed tomographic angiography (CTA). Laboratory tests were performed at the baseline and in dynamics. Patients' consent was received at day of admission to the Academy for diagnosis, in-patient treatment and follow-up examination.
Results
Baseline clinical characteristics are summarized in Table 19 . Laboratory and instrumental tests in the different clinical severity of sepsis are shown in Table 20 . The incidence of all dorsal and plantar STCI on admission in our Centre in 2013 was similar (52.6%/47.3%). Among 179 T2D patients included in this study cohort, 127 (70.95%) had plantar STCI vs. 52 (29.05%) dorsal. The odds ratio of TFA from plantar complications was 2.65 (p = 0.0267). Severe sepsis and septic shock were developed significantly more often in patients with plantar STCI, F(1, 177) = 99.59, p < 0.001, t(177) = 9.88, p < 0.001. The 95% confidence interval for the slope was .18 to .32. The correlation coefficient was 0.62, p < 0.001. Figure 39 shows dorsal synovial injury, Fig. 40 indicates the plantar spread of infection. On CTA stenosis > 50% of the posterior tibial artery was detected in 1.9 times more often than anterior tibial artery 25.6% vs. 32.2%; occlusion 3.8 times higher 70.4% vs. 18.4%, respectively (p < 0.001). The correlation coefficient between plantar STCI and lesions of the posterior tibial artery was r = 0.71, p < 0.001. Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. 
